As in Lewy-body Parkinson's disease, nigral degeneration is a typical finding in LRRK2 mutation and is considered to be the pathological substrate of clinical parkinsonism in these patients (Wider et al., 2010). This evidence concerns the gene LRRK2 and Parkinson disease.